文献速递甲状腺疾病肥胖与代谢综合征

体重指数与甲状腺癌风险:亚洲队列联盟五十万男女性汇总分析

Body Mass Index and Thyroid Cancer Risk: A Pooled Analysis of Half a Million Men and Women in the Asia Cohort Consortium.
PubMed 文献 · Thyroid · 2022-01-11

该汇总分析纳入亚洲13个队列538857名男女性,平均随访15.1年确诊1132例甲状腺癌。以BMI 18.5-22.9 kg/m2为参照,男性BMI 25-29.9组甲状腺癌风险HR 1.31(95%CI 0.95-1.80),BMI≥30组HR 1.84(95%CI 0.89-3.81);女性BMI 23-24.9组HR 1.26(95%CI 1.07-1.48)。男性BMI每增加5单位HR 1.25(95%CI 1.10-1.55),呈线性关联;女性HR 1.07(95%CI 0.97-1.18),未达统计学显著。

要点

  • 男性BMI每增加5单位与甲状腺癌风险升高相关(HR 1.25,95%CI 1.10-1.55)。
  • 女性BMI 23-24.9 kg/m2组甲状腺癌风险升高(HR 1.26,95%CI 1.07-1.48)。
  • 偏瘦与甲状腺癌风险的关联可能因性别和组织学亚型而异。

核心结论

  • 较高BMI在男女性中均与甲状腺癌风险升高相关,而偏瘦BMI的关联可能因性别和组织学亚型而异。

研究设计与样本

  • 亚洲队列联盟汇总分析,13个队列共538857名男女性,基线身高体重在5个队列中测量、8个队列中自我报告,甲状腺癌发病通过 linkage 至当地癌症登记处确认,以队列为分层因素用Cox比例风险模型估计汇总HR和CI,所有分析按性别分层。

主要发现

  • 平均随访15.1年,确诊1132例甲状腺癌。
  • 以BMI 18.5-22.9 kg/m2为参照,男性BMI 25-29.9 kg/m2组甲状腺癌风险HR 1.31(95%CI 0.95-1.80),BMI≥30 kg/m2组HR 1.84(95%CI 0.89-3.81)。
  • 女性BMI 23-24.9 kg/m2组甲状腺癌风险升高,HR 1.26(95%CI 1.07-1.48)。
  • BMI每增加5单位的HR在男性为1.25(95%CI 1.10-1.55),呈线性关联;女性为1.07(95%CI 0.97-1.18),未达统计学显著。
  • 偏瘦男女性 overall 甲状腺癌风险较低,但偏瘦男性乳头状癌风险可能升高(HR 2.24,95%CI 0.75-6.66)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Although previous meta-analyses have suggested a dose-response relationship between body mass index (BMI) and thyroid cancer risk, limited evidence has been presented about Asian populations. To assess this association among Asian populations, where underweight is more prevalent than in other regions, a pooled analysis from the Asia Cohort Consortium was conducted. Methods: Baseline height and weight were measured in five cohorts and self-reported in eight cohorts. Thyroid cancer incidence was ascertained by linkage to local cancer registries. Cohorts were treated as a stratum in the Cox proportional hazard model to estimate the pooled hazard ratios (HRs) and corresponding confidence intervals (CIs) from the estimates for each cohort. All analyses were stratified by sex. Results: A total of 538,857 men and women from 13 cohorts from mainland China, Korea, Japan, and Singapore were included in the analysis. During a mean of 15.1 years of follow-up, 1132 thyroid cancer cases were ascertained. Using a BMI of 18.5-22.9 kg/m2 as a reference, an elevated risk of thyroid cancer was observed for groups with a BMI between 25 and 29.9 kg/m2 (HR: 1.31, [CI: 0.95-1.80]) and a BMI of 30 kg/m2 and greater (HR: 1.84, [CI: 0.89-3.81]) in men. Thyroid cancer risk was elevated in women with a BMI of 23-24.9 kg/m2 (HR: 1.26, [CI: 1.07-1.48]). The HRs for 5-U increment of BMI showed a linear association among men (HR: 1.25, [CI 1.10-1.55]) but not among women (HR: 1.07, [CI: 0.97-1.18]). Although the overall thyroid cancer risk was lower among underweight men and women, the papillary cancer risk may be elevated among underweight men (HR: 2.24, [CI: 0.75-6.66]). Conclusion: While higher BMI is associated with an elevated risk of thyroid cancer in both men and women, the association of underweight BMI may differ by sex and histological subtype.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Shin A, Cho S, Jang D, et al. Body Mass Index and Thyroid Cancer Risk: A Pooled Analysis of Half a Million Men and Women in the Asia Cohort Consortium. Thyroid. 2022. PMID: 34915752. doi:10.1089/thy.2021.0445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。